SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?


To: Edward W. Richmond who wrote (850)6/2/1998 8:55:00 PM
From: Wisee  Read Replies (1) | Respond to of 1185
 
Edward,

You are absolutely right, Nortran is a bargain!!

Forbes Medi-Tech's present market cap. is $126 million, and they have
about half as many exciting drugs in their pipeline.

Nortran should be at least at a similar market cap. as Forbes Medi-Tech. This would equate to a price of $3.88 for Nortran ($126 million/32.5 million shares outstanding).

Wisee